Different mechanisms of Campath-1H-mediated depletion for CD4 and CD8 T cells in peripheral blood.
about
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomesThe effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surfaceHuman peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis.Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity.Receptor-directed therapy of T-cell leukemias and lymphomas.Depleting T-cell subpopulations in organ transplantation.Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeysImpact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.Homeostatic expansion as a barrier to lymphocyte depletion strategies.The immunological function of CD52 and its targeting in organ transplantation.Impact of Immune-Modulatory Drugs on Regulatory T Cell.Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS.Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
P2860
Q26776234-C815D060-0524-493C-8EA7-5BACD722C664Q33933551-39D3B257-608F-4E2E-AB67-A7495B270676Q34326110-8D0AC32C-90C0-44EA-9D8F-5FEB63AA6652Q34376451-3826DFD7-42CD-4545-8B7D-F83BE454870FQ37191195-F60F141D-72FD-4633-907C-B6C49BBF4B35Q37196716-1FF8F8DD-85AD-4E6E-AADA-073517AC228AQ37316082-6D2F7D58-0B1F-493F-95E4-1BA6E9C9BBE9Q37362699-6B554CF8-DA94-4E90-B2EA-D7C61F0C2571Q37652611-63E4C938-7287-4999-BC23-E32DB5915452Q38219995-03FE89B6-A79D-4534-8FFE-194084186940Q38747419-C4A6484E-3487-4A61-861C-E241BEFB5888Q38918124-D9B760E4-342A-439A-B94F-1E07860E5D6AQ39744600-85971DC3-DD71-4D5D-BC2D-981F164205C0Q54146573-9C69D9B6-EA9E-460D-8BF5-A3DC155A2266Q58788563-E98CD522-352B-4017-BF05-4A6A6F078076
P2860
Different mechanisms of Campath-1H-mediated depletion for CD4 and CD8 T cells in peripheral blood.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@en
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@nl
type
label
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@en
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@nl
prefLabel
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@en
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@nl
P2093
P2860
P1476
Different mechanisms of Campat ...... 8 T cells in peripheral blood.
@en
P2093
Abrar Khan
Akeesha Shah
Alan Chant
Hayden Lowenstein
P2860
P304
P356
10.1111/J.1432-2277.2006.00382.X
P577
2006-11-01T00:00:00Z